Back to Search
MICHAEL SAFDI, M.D.
M.D.
Gastroenterology Physician
NPI: 1336138130Individual
Specialties, Licenses & Credentials
Gastroenterology PhysicianPrimary
Internal Medicine — Gastroenterology
Code: 207RG0100X
35-04-1895-S(OH)
Research & Publications (20)
The effects of oral pancreatic enzymes (Creon 10 capsule) on steatorrhea: a multicenter, placebo-controlled, parallel group trial in subjects with chronic pancreatitis.
PMID 16868481·Pancreas·2006
3-trial
Pilot feasibility studies of leukocytapheresis with the Adacolumn Apheresis System in patients with active ulcerative colitis or Crohn disease.
PMID 16825929·J Clin Gastroenterol·2006
3-trial
Quality indicators for endoscopic retrograde cholangiopancreatography.
PMID 16635233·Am J Gastroenterol·2006
6-review
Quality indicators for gastrointestinal endoscopic procedures: an introduction.
PMID 16635230·Am J Gastroenterol·2006
6-review
Quality indicators for endoscopic retrograde cholangiopancreatography.
PMID 16564909·Gastrointest Endosc·2006
6-review
Quality indicators for gastrointestinal endoscopic procedures: an introduction.
PMID 16564906·Gastrointest Endosc·2006
6-review
Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease.
PMID 16500392·Gastrointest Endosc·2006
4-observational
Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trial.
PMID 16279903·Am J Gastroenterol·2005
4-observational
Repifermin (keratinocyte growth factor-2) for the treatment of active ulcerative colitis: a randomized, double-blind, placebo-controlled, dose-escalation trial.
PMID 12786629·Aliment Pharmacol Ther·2003
3-trial
Balsalazide is superior to mesalamine in the time to improvement of signs and symptoms of acute mild-to-moderate ulcerative colitis.
PMID 12492193·Am J Gastroenterol·2002
3-trial
Randomized, controlled trial of recombinant human interleukin-11 in patients with active Crohn's disease.
PMID 11876692·Aliment Pharmacol Ther·2002
3-trial
Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial.
PMID 11677200·Gastroenterology·2001
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2925 VERNON PL, SUITE 100
CINCINNATI, OH 45219 - Phone
- (513) 751-6667
Quick Facts
- NPI
- 1336138130
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile